InvestorsHub Logo
Followers 8
Posts 554
Boards Moderated 0
Alias Born 08/03/2017

Re: None

Sunday, 03/08/2020 11:40:40 AM

Sunday, March 08, 2020 11:40:40 AM

Post# of 3504
Watching for continued movement this week. From Benzinga on March 5: “The company, though it has not disclosed any COVID-19 development, has a vaccine adjuvant in the works.

Its SA-702's immune activity is being harnessed to enhance the efficacy of vaccines by eliciting a stronger immune response to a vaccine's particular antigen.”

Always do your own DD. Any opinions expressed by me are in my opinion and shouldn't be taken as investment advice. Words to live by: "A Fool and His Money are Soon Parted" - Thomas Tusser